Flashback, the classic 16-bit sci-fi platformer from Delphine Software, is, as you probably already know, getting a seq…
Flashback, the classic 16-bit sci-fi platformer from Delphine Software, is, as you probably already know, getting a sequel before the end of 2023, some 31 years after its original release. And new developer Microids has now offered a fresh look at Flashback 2's action - specifically the jungle-y bits - in a new trailer as it prepares for a November release.
The original Flashback, which arrived to much acclaim back in 1992 - when everything was still in black and white, and computers were powered by magic - followed the far-flung future adventures of agent Conrad B. Hart on the trail of shapeshifting aliens attempting to infiltrate human society. It was an investigation that, much like Delphine's earlier Another World, took the form of a strikingly rotoscoped platform-puzzler.
Flashback 2 sees the return of Conrad B. Hart for more space-faring adventures - somewhere in the 22nd century - as he goes in search of his friend Ian. Again.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Flashback to 2000: A magical time for region as Harry Potter fever grips nationWhat were you doing in 2000? Were you one of the excited Harry Potter fans awaiting the publication of JK Rowling's latest book?
Lire la suite »
China says local semiconductor manufacturing not world classChina admits local semiconductor industry can't match world class reliability
Lire la suite »
Chef competition in Grantham shows army’s culinary class🥇👨🍳 It's time for the ultimate cook-off! Army chefs gathered at Grantham barracks to prove their culinary prowess in Exercise Army Sustainer
Lire la suite »
Swiss investors in Credit Suisse join class action challenging UBS deal\n\t\t\tExclusive scoops\n\t\t\tSmart data to help spot risk and opportunity\n\t\t\tAnalysis of broader trends in M&A\n\t\t\tLex, our agenda-setting business commentary (Premium only)\n\t\t\tDue Diligence, an exclusive M&A newsletter (Premium only)\n\t\t
Lire la suite »
Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda - BMC Health Services ResearchBackground Availability and accessibility of anti-cancer medicines is the pillar of cancer management, and it is one of the main concerns in low-income countries including Rwanda. The objective of this study was to assess the availability and affordability of anticancer medicines at cancer-treating hospitals in Rwanda. Methodology A descriptive cross-sectional study was conducted at 5 cancer-treating hospitals in Rwanda. Quantitative data were collected from stock cards and software that manage medicines and included the availability of anti-cancer medicines at the time of data collection, their stock status within the last two years, and the selling price. Results The study found the availability of anti-cancer medicines at 41% in public hospitals at the time of data collection, and 45% within the last two years. We found the availability of anti-cancer medicines at 45% in private hospitals at the time of data collection, and 61% within the last two years. 80% of anti-cancer medicines in private hospitals were unaffordable while 20% were affordable. The public hospital that had most of the anti-cancer medicines in the public sector provided free services to the patients, and no cost was applied to the anti-cancer medicines. Conclusion The availability of anti-cancer medicines in cancer-treating hospitals is low in Rwanda, and most of them are unaffordable. There is a need to design strategies that can increase the availability and affordability of anti-cancer medicines, for the patients to get recommended cancer treatment options.
Lire la suite »
Labour sets out reform of early-years education to break ‘class ceiling’\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Lire la suite »